DANCE Partner: Inflammatory Biomarker Analysis by Femoropopliteal Revascularization Method and Treatment Outcomes
NCT02469532 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 31
Last updated 2018-03-08
Summary
This is a prospective, multi-center, observational registry to document the baseline, 24-hour and 30-day inflammatory response and procedural outcomes out to 12 month follow-up after femoropopliteal angioplasty or atherectomy-based revascularization procedures.
Conditions
- Peripheral Arterial Disease
Interventions
- DEVICE
-
Balloon Angioplasty
Device: Balloon Angioplasty Selection is driven by preference of the operator
- DEVICE
-
Atherectomy System
Device: Orbital or Directional or Laser Atherectomy Systems Atherectomy selection is driven by preference of the operator
Sponsors & Collaborators
-
Mercator MedSystems, Inc.
lead INDUSTRY
Principal Investigators
-
Jason A Yoho, MD · Mission Research, New Braunfels, TX
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-05-31
- Primary Completion
- 2017-10-31
- Completion
- 2018-01-31
Countries
- United States
Study Locations
More Related Trials
-
Tack Optimized Drug Coated Balloon Angioplasty Study of the Tack Endovascular System™ in Femoropoliteal Arteries
NCT02802306 ·Status: COMPLETED ·Phase: NA
-
Use and Safety of the LUTONIX® Drug Coated Balloon Catheter in Arteries of the Lower Extremity
NCT02043951 ·Status: TERMINATED
-
LEVANT 2 Continuation Registry of the Lutonix® Drug Coated Balloon (DCB)
NCT01628159 ·Status: COMPLETED ·Phase: NA
-
Tack Optimized Balloon Angioplasty Post-Market Study
NCT05361967 ·Status: TERMINATED
-
Evaluation of Safety and Efficacy of the S.M.A.R.T. RADIANZ™ Vascular Stent System in the Treatment of Iliac and Femoropopliteal Lesions Via Transradial Access
NCT05399680 ·Status: COMPLETED ·Phase: NA
-
Zilver® Flex™ Vascular Stent Study
NCT00827619 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Combination Therapy for Upper Extremity Lymphedema
NCT05825157 ·Status: RECRUITING ·Phase: NA
-
480 Biomedical Bioresorbable Scaffold System in the Treatment of de Novo Superficial Femoral Artery (SFA) Lesions
NCT01403077 ·Status: COMPLETED ·Phase: NA
-
Tack Optimized Balloon Angioplasty Study of the Tack Endovascular System™ in Femoropoliteal Arteries
NCT02522884 ·Status: COMPLETED ·Phase: NA
-
Constrained Balloon Combined With Drug-coated Balloon Angioplasty for Femoropopliteal Lesion
NCT05894460 ·Status: UNKNOWN
-
Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter
NCT02424383 ·Status: COMPLETED ·Phase: NA
-
Treatment of Patients With Lesions in the Superficial Femoral and/ or Popliteal Arteries Using Kanshas Paclitaxel-coated Balloon Catheter.
NCT02939924 ·Status: COMPLETED ·Phase: NA
-
Paclitaxel-coated Balloons in Femoral Indication to Defeat Restenosis
NCT01083030 ·Status: COMPLETED ·Phase: PHASE3
-
PMCF Study for Peripheral Arteries Above the Knee (ATK)
NCT05312580 ·Status: COMPLETED
-
Angioplasty + SBCV vs. Angioplasty Alone for Femoropopliteal Artery Stenosis
NCT02568293 ·Status: UNKNOWN ·Phase: NA
-
Lutonix Drug Coated Balloon for Treatment of Femoropopliteal Arteries in United States Females (CONFIRM)
NCT02813577 ·Status: TERMINATED ·Phase: NA
-
Prospective Study for the Treatment of Atherosclerotic Lesions in the Superficial Femoral And/or Popliteal Arteries Using the FLEX Scoring Catheter Plus DCB
NCT03676842 ·Status: TERMINATED ·Phase: NA
-
Revolution™ Peripheral Atherectomy System for Lower Extremity Peripheral Arterial Revascularization
NCT02961894 ·Status: COMPLETED ·Phase: NA
-
Evaluation of WIRION™ EPS in Lower Extremities Arteries
NCT02780349 ·Status: COMPLETED ·Phase: NA
-
Drug Coated Balloons for Prevention of Restenosis
NCT00696956 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Safety and Efficacy of the SurVeil™ Drug-Coated Balloon
NCT03241459 ·Status: COMPLETED ·Phase: NA
-
A Multi-Center Study to Evaluate Acute Safety and Clinical Performance of Paladin® Carotid Post-Dilation Balloon System With Integrated Embolic Protection
NCT02501148 ·Status: COMPLETED
-
LEVANT I, The Lutonix Paclitaxel-Coated Balloon for the Prevention of Femoropopliteal Restenosis
NCT00930813 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Post-Market Registry of AURYON Atherectomy Device in Subjects Affected With Infrainguinal Peripheral Artery Disease
NCT04229563 ·Status: COMPLETED
-
LEVANT 2 Safety Registry
NCT01790243 ·Status: COMPLETED ·Phase: NA